Core Services
A Named Patient Program (NPP), also known as a Managed Access Program, allows patients and their treating physicians to access medicines that are approved in at least one country but are not yet available in the patient's own country. Through this program, essential therapies can be imported for patients who require them urgently.
Pharmaceutical companies may not launch every medicine in all regions due to regulatory, commercial, or logistical reasons. In such situations, clinicians can request access to critical medicines—especially for rare diseases, orphan conditions, life-threatening illnesses, or chronic and severely debilitating disorders—via an NPP to treat a specific patient.
Eligibility: The patient must have a life-threatening, chronic, or severely debilitating condition, with no approved treatment available in their country. The patient should also be ineligible for ongoing clinical trials. Medicines requested through NPP must have a favourable benefit-risk profile based on the latest clinical data, and their intended use should align with the approved or investigational indication.
Individual Requests: NPP allows treating physicians to submit requests on behalf of their specific patients.
Access to Medicines: Medicines may be approved in one country but not commercially available or accessible in the patient's country, or there may be shortages locally.
Regulatory Approval in India: Government regulations enable access to such medicines under the NPP, subject to prior approval from the Central Drugs Standard Control Organization (CDSCO) and customs authorities. Medicines can then be imported through authorised distributors.
If you are a physician, patient, or caregiver seeking access to medicines under India's Named Patient Program, please reach out to us for assistance.
Submit Access RequestEnd-to-end support aligned with CDSCO, DCGI & DGFT requirements.
Strong pharmacovigilance systems with strict ABAC compliance.
Validated cold-chain handling with real-time shipment monitoring.
EU-GDP sourced medicines delivered through fully compliant Indian import pathways.
From request to delivery — a simple, guided pathway to help you access medicines not readily available in your country.
Share your prescription and medicine requirements through our platform to initiate the process.
Our team reviews the request for medical validity and checks global availability through verified sources.
You receive a detailed quotation, including pricing, sourcing details, and estimated delivery timelines.
Upon approval, confirm your order and proceed with secure payment to initiate procurement.
We coordinate with authorised global suppliers and manage regulatory documentation for compliant access.
Your medicine is shipped through temperature-controlled logistics and delivered safely to your location.
The Named Patient Program (NPP) is a regulated pathway that allows patients to access medicines that are not yet approved or commercially available in their country. In India, this process enables patients with serious, chronic, or life-threatening conditions to import essential medicines with prior approval from regulatory authorities such as CDSCO, based on a valid prescription from a treating doctor.
Patients diagnosed with serious or life-threatening conditions, where approved treatment options are limited or unavailable locally, can access medicines through the Named Patient Program. The request must be supported by a licensed medical practitioner who prescribes the required treatment.
The process typically includes:
A reliable NPP facilitator ensures compliance with all regulatory requirements throughout the process.
Yes, importing medicines through the Named Patient Program is legal in India when done in compliance with regulatory guidelines, including approvals from CDSCO and adherence to DGFT import regulations.
Yes, a valid prescription from a registered medical practitioner is mandatory. Medicines cannot be sourced or supplied without proper medical authorisation.
The cost of medicines under NPP depends on several factors:
A detailed quotation is provided before proceeding with the order.
To initiate the process, the following documents are typically required:
Additional documents may be required based on regulatory requirements.
Timelines vary depending on:
Typically, the process may take a few days to a few weeks, depending on the complexity.
Yes, hospitals and healthcare providers can initiate requests on behalf of patients to ensure timely access to required therapies.
NPP enables access to:
Yes, medicines are sourced from authorised manufacturers and licensed distributors, ensuring authenticity, quality, and compliance with global standards.
An NPP facilitator like Ikris Pharma supports the entire process, including:
This ensures a smooth, compliant, and hassle-free experience for patients and healthcare providers.
Yes, medicines can be delivered across India, subject to regulatory approvals and logistics feasibility, including temperature-controlled shipping where required.
We support delivery across all major cities and regions, including Delhi NCR (Delhi, Noida, Gurgaon), Mumbai, Navi Mumbai, Pune, Bangalore, Hyderabad, Chennai, Kolkata, Ahmedabad, Surat, Jaipur, Lucknow, Chandigarh, Bhopal, Indore, Patna, Ranchi, Bhubaneswar, Guwahati, Kochi, Thiruvananthapuram, Coimbatore, Nagpur, Vadodara, Visakhapatnam, and many more.
Our network ensures pan-India coverage, including Tier 1, Tier 2, and remote locations, with secure and compliant delivery.
Get in Touch with Our Team
Looking for a reliable partner for pharmaceutical exports from India or Reference Listed Drug (RLD) services? Ikris Pharma Network combines regulatory expertise, verified sourcing, and a precision-driven supply process to meet your requirements with confidence.
Submit your requirement today and receive a prompt response from our specialists.
Mail Us Now
Office Address
905, I-Thum Business Park, Plot No. A-40, Unit No. 5, Tower A, Sector-62, Noida – 201301 (India)